September 13, 2021
Antimicrobial resistance (AMR) is a prominent public health threat that is already impacting hundreds of thousands of patients each year and jeopardizing the level of care in health systems around the world.
The effects of AMR threaten not only the application of modern medicine and ability to achieve good health but also have implications across society, from affecting agriculture and food security to economic development and beyond.
Low- and lower middle-income countries are disproportionately burdened by the drivers of and effects from AMR and limited access to antimicrobials and treatment. However, the challenges are real across the world and have no borders.
Addressing AMR requires a holistic approach and multi-stakeholder cooperation. An effective response needs to prioritize access to antimicrobials, stewardship measures – including appropriate use and surveillance – and responsible manufacturing. As a global healthcare company, we consider the diverse needs and circumstances of patients and communities across the world by supporting and developing measures to address AMR while taking care to avoid unintended consequences.
We are founding members of the AMR Industry Alliance, a coalition of industry participants focused on reducing the threat of AMR through partnerships and collective action. The Alliance recently launched its inaugural Stewardship Prize for innovation and scalable stewardship programs in low and lower-middle income countries. They are now accepting applications and will be awarding a cash prize to fund an innovative program that addresses stewardship and appropriate use of antibiotics in LMICs.
Applications are due by Oct. 8, 2021 and can be submitted at https://www.surveymonkey.com/r/35PBZFD
To learn more about Viatris’ efforts to combat AMR, read our 2020 Sustainability Report.